US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MiNK Therapeutics, Inc.

11.01

+0.04000.36%

Post-market: 11.010.00000.00%18:32 EST

Volume:5.49K

Turnover:61.11K

Market Cap:51.68M

PE:-3.64

High:11.48

Open:10.97

Low:10.97

Close:10.97

52wk High:76.00

52wk Low:6.34

Shares:4.69M

Float Shares:1.70M

Volume Ratio:0.48

T/O Rate:0.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.0219

EPS(LYR):-2.8582

ROE:-1238.98%

ROA:-69.61%

PB:-3.82

PE(LYR):-3.85

Loading ...

Overview Company News Filings

MiNK Therapeutics announces new invariant natural killer T cells data

MiNK Therapeutics Unveils Data Supporting iNKT Cell Therapy for Advanced Idiopathic Pulmonary Fibrosis

MiNK, University of Wisconsin-Madison announce Phase 1 agenT-797 trial

MiNK Therapeutics Wins Grants to Advance Phase 1 Trial of Allo-iNKT Cell Therapy for GvHD Prevention

Mink Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-Inkt Cell Therapy (Agent-797) to Evaluate Prevention of Graft-Versus-Host Disease

THOMSON REUTERS

MiNK Therapeutics Director Robert Kadlec Resigns for U.S. Government Role

MiNK Therapeutics Reports MiNK-215 Shows Strong Anti-Tumor Activity in Resistant Solid Tumors

MiNK Therapeutics: Advancing Clinical Trials and Strategic Partnerships to Address GvHD and Pulmonary Diseases

MiNK Therapeutics Q3 EPS $(0.65) Misses $(0.61) Estimate

MiNK Therapeutics reports Q3 EPS (65c) vs (46c) last year

Mink Therapeutics Q3 EPS USD -0.65

THOMSON REUTERS

Mink Therapeutics Inc: Cash Runway Extended Through 2026, Enabling Multiple Inflection Points

THOMSON REUTERS

Mink Therapeutics Reports Q3 2025 Results and Accelerates Inkt Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation

THOMSON REUTERS

Press Release: MiNK Therapeutics Reports Q3 2025 Results and Accelerates iNKT Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation

BRIEF-Mink Therapeutics Inc - Files For Mixed Shelf Offering Up To $150 Million - SEC Filing

MiNK Therapeutics files $150M mixed securities shelf

Promising Phase 1 Results for MiNK Therapeutics’ agenT-797 Support Buy Rating

BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton Interactive

BUZZ-MiNK Therapeutics rises after data shows long-lasting remissions in tough cancers

MiNK Therapeutics reports updated clinical results on agenT-797

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/INKT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INKT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INKT\",,,,,undefined,":{"symbol":"INKT","market":"US","secType":"STK","nameCN":"MiNK Therapeutics, Inc.","latestPrice":11.01,"timestamp":1770670800000,"preClose":10.97,"halted":0,"volume":5492,"hourTrading":{"tag":"盘后","latestPrice":11.01,"preClose":11.01,"latestTime":"18:32 EST","volume":38,"amount":425.1086,"timestamp":1770679932289,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0036463081130354734,"floatShares":1703200,"shares":4694155,"eps":-3.021903,"marketStatus":"Closed","change":0.04,"latestTime":"02-09 16:00:00 EST","open":10.97,"high":11.48,"low":10.97,"amount":61106.3257,"amplitude":0.04649,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.021903,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":5,"adr":0,"listingDate":1634270400000,"exchange":"NASDAQ","adjPreClose":10.97,"preHourTrading":{"tag":"盘前","latestPrice":11.1,"preClose":10.97,"latestTime":"09:29 EST","volume":20,"amount":222,"timestamp":1770647397024,"change":0.13,"changeRate":0.011851,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":11.01,"preClose":11.01,"latestTime":"18:32 EST","volume":38,"amount":425.1086,"timestamp":1770679932289,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.480784},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INKT\",,,,,undefined,":{"symbol":"INKT","floatShares":1703200,"roa":"-69.61%","roe":"-1238.98%","lyrEps":-2.858168,"volumeRatio":0.480784,"shares":4694155,"dividePrice":0,"high":11.48,"amplitude":0.04649,"preClose":10.97,"low":10.97,"week52Low":6.34,"pbRate":"-3.82","week52High":76,"institutionHeld":0,"latestPrice":11.01,"eps":-3.021903,"divideRate":0,"volume":5492,"delay":0,"ttmEps":-3.021903,"open":10.97,"prevYearClose":11.15,"prevWeekClose":10.97,"prevMonthClose":11.78,"prevQuarterClose":11.15,"fiveDayClose":11.62,"twentyDayClose":12.4,"sixtyDayClose":13.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INKT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"INKT","fiscalQuarterEnding":"2025/09","expectedEps":-0.86,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-0.65},{"market":"US","date":"2025-08-14","symbol":"INKT","fiscalQuarterEnding":"2025/06","expectedEps":-0.55,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-1.06},{"market":"US","date":"2025-05-15","symbol":"INKT","fiscalQuarterEnding":"2025/03","expectedEps":-0.61,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.7},{"market":"US","date":"2025-03-18","symbol":"INKT","fiscalQuarterEnding":"2024/12","expectedEps":-0.5,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"pre","actualEps":-0.62},{"market":"US","date":"2025-01-28","symbol":"INKT","defaultRemindTime":1738074600000,"type":"split","dateTimestamp":1738040400000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INKT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INKT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1755234000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INKT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INKT","date":"2026-02-06","current":-3.655246,"percent":0.194497,"low":-37.223699,"twenty":-4.128815,"median":-2.678877,"eighty":-1.686479,"high":-1.078214,"avg":-3.80651,"sd":5.043269,"marketCap":51729588},"quantilePoints":[{"date":"2021-10-15","current":-22.300768,"twenty":-24.056031,"median":-24.056031,"eighty":-23.002873,"marketCap":396052188},{"date":"2021-10-22","current":-22.375104,"twenty":-23.792508,"median":-22.598112,"eighty":-22.330502,"marketCap":397372361},{"date":"2021-10-29","current":-33.246729,"twenty":-24.742333,"median":-23.118463,"eighty":-22.330502,"marketCap":590447803},{"date":"2021-11-05","current":-32.298946,"twenty":-34.406369,"median":-24.056031,"eighty":-22.419706,"marketCap":573615585},{"date":"2021-11-12","current":-30.477717,"twenty":-35.268665,"median":-26.965346,"eighty":-22.575811,"marketCap":541271323},{"date":"2021-11-19","current":-29.69719,"twenty":-35.220347,"median":-29.901613,"eighty":-22.873155,"marketCap":527409497},{"date":"2021-11-26","current":-37.186531,"twenty":-35.22778,"median":-30.91444,"eighty":-23.174215,"marketCap":660417023},{"date":"2021-12-03","current":-13.513422,"twenty":-35.194329,"median":-29.734358,"eighty":-22.315635,"marketCap":351125588},{"date":"2021-12-10","current":-7.891426,"twenty":-35.116276,"median":-26.082607,"eighty":-15.473385,"marketCap":205046622},{"date":"2021-12-17","current":-5.505946,"twenty":-34.540173,"median":-24.056031,"eighty":-10.511586,"marketCap":143063574},{"date":"2021-12-23","current":-6.03462,"twenty":-33.246729,"median":-23.118463,"eighty":-8.665095,"marketCap":156800358},{"date":"2021-12-31","current":-5.750941,"twenty":-32.391866,"median":-22.430856,"eighty":-6.614872,"marketCap":149429401},{"date":"2022-01-07","current":-5.1449,"twenty":-32.298946,"median":-22.282184,"eighty":-5.738047,"marketCap":133682356},{"date":"2022-01-14","current":-4.087552,"twenty":-31.574171,"median":-16.09232,"eighty":-5.544629,"marketCap":106208789},{"date":"2022-01-21","current":-4.02308,"twenty":-31.470101,"median":-14.345117,"eighty":-5.418263,"marketCap":104533572},{"date":"2022-01-28","current":-3.726507,"twenty":-31.369747,"median":-9.761127,"eighty":-5.175847,"marketCap":96827571},{"date":"2022-02-04","current":-4.13913,"twenty":-30.652406,"median":-8.748909,"eighty":-4.652331,"marketCap":107548963},{"date":"2022-02-11","current":-3.597562,"twenty":-30.150639,"median":-6.963023,"eighty":-4.237128,"marketCap":93477136},{"date":"2022-02-18","current":-3.210727,"twenty":-29.80126,"median":-6.369877,"eighty":-4.123657,"marketCap":83425831},{"date":"2022-02-25","current":-3.339672,"twenty":-29.712057,"median":-5.892781,"eighty":-4.061763,"marketCap":86776266},{"date":"2022-03-04","current":-3.752296,"twenty":-28.058084,"median":-5.725152,"eighty":-3.899293,"marketCap":97497658},{"date":"2022-03-11","current":-2.952837,"twenty":-25.906059,"median":-5.557524,"eighty":-3.780663,"marketCap":76724961},{"date":"2022-03-18","current":-3.487668,"twenty":-24.513566,"median":-5.505946,"eighty":-3.726507,"marketCap":105372120},{"date":"2022-03-25","current":-2.72127,"twenty":-24.056031,"median":-5.35766,"eighty":-3.669771,"marketCap":82217100},{"date":"2022-04-01","current":-2.610198,"twenty":-23.660746,"median":-5.183584,"eighty":-3.582088,"marketCap":78861300},{"date":"2022-04-08","current":-3.054487,"twenty":-23.229967,"median":-4.874116,"eighty":-3.378356,"marketCap":92284500},{"date":"2022-04-14","current":-3.254417,"twenty":-22.954924,"median":-4.648462,"eighty":-3.355146,"marketCap":98324940},{"date":"2022-04-22","current":-2.543554,"twenty":-22.620413,"median":-4.332548,"eighty":-3.278852,"marketCap":76847820},{"date":"2022-04-29","current":-2.488018,"twenty":-22.442006,"median":-4.177814,"eighty":-3.202991,"marketCap":75169920},{"date":"2022-05-06","current":-2.165909,"twenty":-22.34537,"median":-4.126236,"eighty":-3.091194,"marketCap":65438100},{"date":"2022-05-13","current":-2.747969,"twenty":-22.293334,"median":-4.087552,"eighty":-2.86808,"marketCap":43293579},{"date":"2022-05-20","current":-2.790574,"twenty":-22.06661,"median":-4.010185,"eighty":-2.747969,"marketCap":43964797},{"date":"2022-05-27","current":-3.557449,"twenty":-19.895501,"median":-3.965054,"eighty":-2.747969,"marketCap":56046726},{"date":"2022-06-03","current":-3.514845,"twenty":-16.711255,"median":-3.829663,"eighty":-2.752229,"marketCap":55375508},{"date":"2022-06-10","current":-3.47224,"twenty":-15.04013,"median":-3.803874,"eighty":-2.773532,"marketCap":54704289},{"date":"2022-06-17","current":-3.429636,"twenty":-14.71261,"median":-3.797427,"eighty":-2.790574,"marketCap":54033071},{"date":"2022-06-24","current":-3.216615,"twenty":-13.732629,"median":-3.778085,"eighty":-2.790574,"marketCap":50676980},{"date":"2022-07-01","current":-2.982292,"twenty":-13.513422,"median":-3.726507,"eighty":-2.811876,"marketCap":46985279},{"date":"2022-07-08","current":-2.811876,"twenty":-10.511586,"median":-3.713612,"eighty":-2.811876,"marketCap":44300406},{"date":"2022-07-15","current":-2.705365,"twenty":-9.224716,"median":-3.680095,"eighty":-2.765011,"marketCap":42622360},{"date":"2022-07-22","current":-2.939688,"twenty":-8.884301,"median":-3.636245,"eighty":-2.786313,"marketCap":46314061},{"date":"2022-07-29","current":-2.790574,"twenty":-8.698621,"median":-3.603705,"eighty":-2.790574,"marketCap":43964797},{"date":"2022-08-05","current":-2.875782,"twenty":-8.04616,"median":-3.557449,"eighty":-2.786313,"marketCap":45307233},{"date":"2022-08-12","current":-1.691835,"twenty":-7.148704,"median":-3.523471,"eighty":-2.747969,"marketCap":57389162},{"date":"2022-08-19","current":-2.588795,"twenty":-6.901129,"median":-3.487668,"eighty":-2.747969,"marketCap":87815189},{"date":"2022-08-26","current":-2.339873,"twenty":-6.669029,"median":-3.423337,"eighty":-2.740426,"marketCap":79371421},{"date":"2022-09-02","current":-2.568881,"twenty":-6.222879,"median":-3.378356,"eighty":-2.707695,"marketCap":87139688},{"date":"2022-09-09","current":-2.777976,"twenty":-6.070724,"median":-3.339672,"eighty":-2.698398,"marketCap":94232453},{"date":"2022-09-16","current":-2.389657,"twenty":-5.864413,"median":-3.318504,"eighty":-2.666174,"marketCap":81060175},{"date":"2022-09-23","current":-1.96151,"twenty":-5.743205,"median":-3.298845,"eighty":-2.620846,"marketCap":66536893},{"date":"2022-09-30","current":-2.100907,"twenty":-5.73031,"median":-3.280522,"eighty":-2.609602,"marketCap":71265404},{"date":"2022-10-07","current":-2.180562,"twenty":-5.686469,"median":-3.259219,"eighty":-2.58847,"marketCap":73967409},{"date":"2022-10-14","current":-1.881855,"twenty":-5.606523,"median":-3.234098,"eighty":-2.550218,"marketCap":63834887},{"date":"2022-10-21","current":-1.971467,"twenty":-5.554945,"median":-3.216615,"eighty":-2.520619,"marketCap":66874644},{"date":"2022-10-28","current":-2.021252,"twenty":-5.529156,"median":-3.196573,"eighty":-2.483575,"marketCap":68563398},{"date":"2022-11-04","current":-3.172412,"twenty":-5.511104,"median":-3.174011,"eighty":-2.476911,"marketCap":82437666},{"date":"2022-11-11","current":-3.900507,"twenty":-5.459526,"median":-3.185989,"eighty":-2.476911,"marketCap":101357787},{"date":"2022-11-18","current":-3.458449,"twenty":-5.397632,"median":-3.210727,"eighty":-2.483575,"marketCap":89870571},{"date":"2022-11-25","current":-3.341434,"twenty":-5.361528,"median":-3.216615,"eighty":-2.488018,"marketCap":86829837},{"date":"2022-12-02","current":-3.276425,"twenty":-5.328002,"median":-3.243208,"eighty":-2.488018,"marketCap":85140541},{"date":"2022-12-09","current":-3.256923,"twenty":-5.260951,"median":-3.250422,"eighty":-2.492461,"marketCap":84633752},{"date":"2022-12-16","current":-2.951383,"twenty":-5.16811,"median":-3.250422,"eighty":-2.513454,"marketCap":76694058},{"date":"2022-12-23","current":-3.016392,"twenty":-5.108796,"median":-3.232202,"eighty":-2.534948,"marketCap":78383355},{"date":"2022-12-30","current":-3.393441,"twenty":-4.98243,"median":-3.216615,"eighty":-2.536669,"marketCap":88181274},{"date":"2023-01-06","current":-3.07958,"twenty":-4.693593,"median":-3.216615,"eighty":-2.543554,"marketCap":80025351},{"date":"2023-01-13","current":-3.068398,"twenty":-4.65491,"median":-3.196573,"eighty":-2.543554,"marketCap":79734792},{"date":"2023-01-20","current":-2.964385,"twenty":-4.644594,"median":-3.175339,"eighty":-2.55244,"marketCap":77031918},{"date":"2023-01-27","current":-2.912378,"twenty":-4.6317,"median":-3.165559,"eighty":-2.566037,"marketCap":75680480},{"date":"2023-02-03","current":-2.886375,"twenty":-4.391863,"median":-3.100903,"eighty":-2.568881,"marketCap":75004762},{"date":"2023-02-10","current":-2.860371,"twenty":-4.308927,"median":-3.0814,"eighty":-2.584163,"marketCap":74329043},{"date":"2023-02-17","current":-2.743356,"twenty":-4.254433,"median":-3.073989,"eighty":-2.588633,"marketCap":71288310},{"date":"2023-02-24","current":-2.743356,"twenty":-4.226813,"median":-3.067501,"eighty":-2.588795,"marketCap":71288310},{"date":"2023-03-03","current":-2.788862,"twenty":-4.170077,"median":-3.024896,"eighty":-2.588795,"marketCap":72470817},{"date":"2023-03-10","current":-2.600338,"twenty":-4.131394,"median":-3.011688,"eighty":-2.595721,"marketCap":67571858},{"date":"2023-03-17","current":-2.886375,"twenty":-4.126236,"median":-3.003594,"eighty":-2.600338,"marketCap":75004762},{"date":"2023-03-24","current":-2.435067,"twenty":-4.118499,"median":-3.00339,"eighty":-2.588795,"marketCap":68160482},{"date":"2023-03-31","current":-2.295747,"twenty":-4.110457,"median":-2.990388,"eighty":-2.563815,"marketCap":64260753},{"date":"2023-04-06","current":-2.265461,"twenty":-4.100141,"median":-2.982292,"eighty":-2.543554,"marketCap":63412986},{"date":"2023-04-14","current":-2.750051,"twenty":-4.087552,"median":-2.979839,"eighty":-2.543554,"marketCap":76977261},{"date":"2023-04-21","current":-2.435067,"twenty":-4.061763,"median":-2.972836,"eighty":-2.53839,"marketCap":68160482},{"date":"2023-04-28","current":-2.277575,"twenty":-4.017922,"median":-2.958611,"eighty":-2.534948,"marketCap":63752093},{"date":"2023-05-05","current":-1.514345,"twenty":-4.005027,"median":-2.951383,"eighty":-2.488018,"marketCap":42388360},{"date":"2023-05-12","current":-1.962591,"twenty":-3.994098,"median":-2.948132,"eighty":-2.479557,"marketCap":54935314},{"date":"2023-05-19","current":-2.285931,"twenty":-3.987343,"median":-2.939688,"eighty":-2.4702,"marketCap":59205948},{"date":"2023-05-26","current":-2.578317,"twenty":-3.984034,"median":-2.921883,"eighty":-2.4702,"marketCap":66778802},{"date":"2023-06-02","current":-2.392253,"twenty":-3.975935,"median":-2.912378,"eighty":-2.469312,"marketCap":61959713},{"date":"2023-06-09","current":-2.977026,"twenty":-3.940487,"median":-2.912378,"eighty":-2.466506,"marketCap":77105421},{"date":"2023-06-16","current":-3.189671,"twenty":-3.915769,"median":-2.912378,"eighty":-2.469312,"marketCap":82612951},{"date":"2023-06-23","current":-4.419023,"twenty":-3.919584,"median":-2.921883,"eighty":-2.469312,"marketCap":114453359},{"date":"2023-06-30","current":-2.777671,"twenty":-3.904322,"median":-2.926214,"eighty":-2.471089,"marketCap":71942111},{"date":"2023-07-06","current":-2.658059,"twenty":-3.886829,"median":-2.918386,"eighty":-2.473684,"marketCap":68844126},{"date":"2023-07-14","current":-2.471995,"twenty":-3.851652,"median":-2.909897,"eighty":-2.473961,"marketCap":64025037},{"date":"2023-07-21","current":-2.445414,"twenty":-3.829663,"median":-2.897284,"eighty":-2.471718,"marketCap":63336595},{"date":"2023-07-28","current":-2.219479,"twenty":-3.819347,"median":-2.892724,"eighty":-2.464872,"marketCap":57484845},{"date":"2023-08-04","current":-2.285931,"twenty":-3.803522,"median":-2.886375,"eighty":-2.444319,"marketCap":59205948},{"date":"2023-08-11","current":-2.551736,"twenty":-3.798505,"median":-2.873373,"eighty":-2.438476,"marketCap":66090360},{"date":"2023-08-18","current":-2.217831,"twenty":-3.791455,"median":-2.870703,"eighty":-2.432124,"marketCap":57628921},{"date":"2023-08-25","current":-2.071746,"twenty":-3.780663,"median":-2.857464,"eighty":-2.423268,"marketCap":53833004},{"date":"2023-09-01","current":-1.925661,"twenty":-3.762611,"median":-2.85448,"eighty":-2.404114,"marketCap":50037087},{"date":"2023-09-07","current":-1.938942,"twenty":-3.757454,"median":-2.85448,"eighty":-2.396135,"marketCap":50382170},{"date":"2023-09-15","current":-1.673333,"twenty":-3.736823,"median":-2.84737,"eighty":-2.386511,"marketCap":43480503},{"date":"2023-09-21","current":-1.766296,"twenty":-3.726507,"median":-2.834368,"eighty":-2.339404,"marketCap":45896086},{"date":"2023-09-29","current":-1.673333,"twenty":-3.721349,"median":-2.827272,"eighty":-2.318672,"marketCap":43480503},{"date":"2023-10-06","current":-1.527249,"twenty":-3.708454,"median":-2.811876,"eighty":-2.300255,"marketCap":39684586},{"date":"2023-10-13","current":-1.513968,"twenty":-3.694535,"median":-2.795363,"eighty":-2.295747,"marketCap":39339503},{"date":"2023-10-20","current":-1.394444,"twenty":-3.681128,"median":-2.795363,"eighty":-2.285931,"marketCap":36233752},{"date":"2023-10-27","current":-1.208518,"twenty":-3.676995,"median":-2.795363,"eighty":-2.279759,"marketCap":31402585},{"date":"2023-11-03","current":-1.367884,"twenty":-3.664613,"median":-2.790574,"eighty":-2.259014,"marketCap":35543586},{"date":"2023-11-10","current":-1.474127,"twenty":-3.641403,"median":-2.777976,"eighty":-2.229732,"marketCap":38304252},{"date":"2023-11-17","current":-1.375696,"twenty":-3.636245,"median":-2.773515,"eighty":-2.215242,"marketCap":34073530},{"date":"2023-11-24","current":-1.421532,"twenty":-3.631448,"median":-2.769315,"eighty":-2.196794,"marketCap":35209930},{"date":"2023-12-01","current":-1.463342,"twenty":-3.620276,"median":-2.750051,"eighty":-2.167489,"marketCap":36245517},{"date":"2023-12-08","current":-1.421532,"twenty":-3.61496,"median":-2.748037,"eighty":-2.120821,"marketCap":35209930},{"date":"2023-12-15","current":-1.505152,"twenty":-3.611893,"median":-2.747969,"eighty":-2.096924,"marketCap":37281103},{"date":"2023-12-22","current":-1.407596,"twenty":-3.602476,"median":-2.74342,"eighty":-2.061079,"marketCap":34864735},{"date":"2023-12-29","current":-1.533025,"twenty":-3.589825,"median":-2.743356,"eighty":-2.053113,"marketCap":37971494},{"date":"2024-01-05","current":-1.560898,"twenty":-3.566615,"median":-2.740578,"eighty":-2.045153,"marketCap":38661884},{"date":"2024-01-12","current":-1.365786,"twenty":-3.557735,"median":-2.730355,"eighty":-2.017158,"marketCap":33829149},{"date":"2024-01-19","current":-1.205794,"twenty":-3.544668,"median":-2.72127,"eighty":-1.987398,"marketCap":29866306},{"date":"2024-01-26","current":-1.198547,"twenty":-3.533717,"median":-2.712816,"eighty":-1.962159,"marketCap":29686804},{"date":"2024-02-02","current":-1.252899,"twenty":-3.521746,"median":-2.704351,"eighty":-1.940534,"marketCap":31033066},{"date":"2024-02-09","current":-1.198686,"twenty":-3.514845,"median":-2.684639,"eighty":-1.909187,"marketCap":29690256},{"date":"2024-02-16","current":-1.296103,"twenty":-3.498539,"median":-2.684063,"eighty":-1.809428,"marketCap":32103172},{"date":"2024-02-23","current":-1.292201,"twenty":-3.481497,"median":-2.677362,"eighty":-1.758328,"marketCap":32006517},{"date":"2024-03-01","current":-1.283978,"twenty":-3.466724,"median":-2.665605,"eighty":-1.713175,"marketCap":31802852},{"date":"2024-03-08","current":-1.297496,"twenty":-3.453248,"median":-2.658059,"eighty":-1.673333,"marketCap":32137691},{"date":"2024-03-15","current":-1.240356,"twenty":-3.439123,"median":-2.655201,"eighty":-1.625524,"marketCap":30722390},{"date":"2024-03-22","current":-1.240356,"twenty":-3.424597,"median":-2.639343,"eighty":-1.572402,"marketCap":30722390},{"date":"2024-03-28","current":-1.406017,"twenty":-3.414868,"median":-2.622846,"eighty":-1.553809,"marketCap":31576140},{"date":"2024-04-05","current":-2.070399,"twenty":-3.405409,"median":-2.619412,"eighty":-1.533025,"marketCap":46496735},{"date":"2024-04-12","current":-1.575976,"twenty":-3.40054,"median":-2.613469,"eighty":-1.535435,"marketCap":35393037},{"date":"2024-04-19","current":-1.346841,"twenty":-3.391822,"median":-2.611769,"eighty":-1.524363,"marketCap":30247167},{"date":"2024-04-26","current":-1.346069,"twenty":-3.384366,"median":-2.608709,"eighty":-1.514043,"marketCap":30229817},{"date":"2024-05-03","current":-1.498008,"twenty":-3.380022,"median":-2.600403,"eighty":-1.501581,"marketCap":33642042},{"date":"2024-05-10","current":-1.389682,"twenty":-3.378356,"median":-2.588795,"eighty":-1.491335,"marketCap":31209292},{"date":"2024-05-17","current":-1.753313,"twenty":-3.373572,"median":-2.588389,"eighty":-1.491335,"marketCap":36092143},{"date":"2024-05-24","current":-1.66059,"twenty":-3.354436,"median":-2.568881,"eighty":-1.494743,"marketCap":34183424},{"date":"2024-05-31","current":-1.834832,"twenty":-3.354436,"median":-2.56833,"eighty":-1.498008,"marketCap":37770224},{"date":"2024-06-07","current":-1.873058,"twenty":-3.341434,"median":-2.555438,"eighty":-1.500688,"marketCap":38557104},{"date":"2024-06-14","current":-1.847027,"twenty":-3.340024,"median":-2.551736,"eighty":-1.504259,"marketCap":38021265},{"date":"2024-06-21","current":-1.664007,"twenty":-3.339672,"median":-2.551736,"eighty":-1.510442,"marketCap":34253782},{"date":"2024-06-28","current":-1.778562,"twenty":-3.339672,"median":-2.547918,"eighty":-1.513968,"marketCap":36611904},{"date":"2024-07-05","current":-1.723867,"twenty":-3.326435,"median":-2.543827,"eighty":-1.513968,"marketCap":35485989},{"date":"2024-07-12","current":-1.852765,"twenty":-3.31697,"median":-2.538446,"eighty":-1.514057,"marketCap":38139368},{"date":"2024-07-15","current":-2.141924,"twenty":-3.315431,"median":-2.536697,"eighty":-1.514079,"marketCap":44091755},{"date":"2024-08-02","current":-1.717364,"twenty":-3.315121,"median":-2.534948,"eighty":-1.514132,"marketCap":35352139},{"date":"2024-08-09","current":-1.54907,"twenty":-3.312502,"median":-2.523913,"eighty":-1.514354,"marketCap":31887787},{"date":"2024-08-16","current":-1.894958,"twenty":-3.306069,"median":-2.511866,"eighty":-1.514354,"marketCap":32384771},{"date":"2024-08-23","current":-1.868711,"twenty":-3.302308,"median":-2.493297,"eighty":-1.515328,"marketCap":31936206},{"date":"2024-08-30","current":-1.82776,"twenty":-3.301228,"median":-2.488018,"eighty":-1.519557,"marketCap":31236354},{"date":"2024-09-06","current":-1.82776,"twenty":-3.298845,"median":-2.483526,"eighty":-1.521434,"marketCap":31236354},{"date":"2024-09-13","current":-1.766912,"twenty":-3.282926,"median":-2.476911,"eighty":-1.523641,"marketCap":30196460},{"date":"2024-09-20","current":-1.774547,"twenty":-3.280522,"median":-2.471995,"eighty":-1.527249,"marketCap":30326941},{"date":"2024-09-27","current":-1.758351,"twenty":-3.280522,"median":-2.470422,"eighty":-1.527249,"marketCap":30050163},{"date":"2024-10-04","current":-1.70028,"twenty":-3.280522,"median":-2.465804,"eighty":-1.529841,"marketCap":29057717},{"date":"2024-10-11","current":-1.550126,"twenty":-3.276425,"median":-2.454052,"eighty":-1.533025,"marketCap":26491591},{"date":"2024-10-18","current":-1.55082,"twenty":-3.276425,"median":-2.443589,"eighty":-1.533025,"marketCap":26503453},{"date":"2024-10-25","current":-1.67483,"twenty":-3.265524,"median":-2.435067,"eighty":-1.538558,"marketCap":28622780},{"date":"2024-10-31","current":-1.66812,"twenty":-3.263844,"median":-2.432124,"eighty":-1.543771,"marketCap":28508115},{"date":"2024-11-08","current":-1.700974,"twenty":-3.263424,"median":-2.430317,"eighty":-1.548271,"marketCap":29069579},{"date":"2024-11-15","current":-1.735215,"twenty":-3.263424,"median":-2.420104,"eighty":-1.549915,"marketCap":29654766},{"date":"2024-11-22","current":-1.980018,"twenty":-3.26006,"median":-2.405543,"eighty":-1.550681,"marketCap":27284362},{"date":"2024-11-29","current":-2.102449,"twenty":-3.257841,"median":-2.398723,"eighty":-1.551791,"marketCap":28972373},{"date":"2024-12-06","current":-1.959088,"twenty":-3.255419,"median":-2.390955,"eighty":-1.553261,"marketCap":26996812},{"date":"2024-12-13","current":-1.808124,"twenty":-3.25202,"median":-2.386365,"eighty":-1.553809,"marketCap":24916484},{"date":"2024-12-20","current":-1.435593,"twenty":-3.250422,"median":-2.339482,"eighty":-1.551791,"marketCap":19782897},{"date":"2024-12-27","current":-1.515093,"twenty":-3.250422,"median":-2.334504,"eighty":-1.547282,"marketCap":20878431},{"date":"2025-01-03","current":-2.898739,"twenty":-3.247536,"median":-2.327858,"eighty":-1.549281,"marketCap":39945474},{"date":"2025-01-10","current":-2.23863,"twenty":-3.235994,"median":-2.334504,"eighty":-1.550126,"marketCap":30848980},{"date":"2025-01-17","current":-2.387872,"twenty":-3.232202,"median":-2.339092,"eighty":-1.55082,"marketCap":32905579},{"date":"2025-01-24","current":-2.798574,"twenty":-3.219732,"median":-2.339873,"eighty":-1.552115,"marketCap":38565180},{"date":"2025-01-31","current":-1.981478,"twenty":-3.216615,"median":-2.339482,"eighty":-1.553535,"marketCap":27305345},{"date":"2025-02-07","current":-3.192221,"twenty":-3.216615,"median":-2.365672,"eighty":-1.553809,"marketCap":43989744},{"date":"2025-02-14","current":-2.654432,"twenty":-3.216615,"median":-2.38724,"eighty":-1.553809,"marketCap":36578859},{"date":"2025-02-21","current":-2.834778,"twenty":-3.213082,"median":-2.390955,"eighty":-1.554293,"marketCap":39064081},{"date":"2025-02-28","current":-2.617046,"twenty":-3.202991,"median":-2.398723,"eighty":-1.558161,"marketCap":36063664},{"date":"2025-03-07","current":-2.346714,"twenty":-3.196321,"median":-2.395488,"eighty":-1.560749,"marketCap":32338406},{"date":"2025-03-14","current":-2.294948,"twenty":-3.193458,"median":-2.389657,"eighty":-1.564152,"marketCap":31625059},{"date":"2025-03-21","current":-3.090383,"twenty":-3.190691,"median":-2.392253,"eighty":-1.566782,"marketCap":33329166},{"date":"2025-03-28","current":-3.392734,"twenty":-3.193458,"median":-2.403757,"eighty":-1.568017,"marketCap":36589966},{"date":"2025-04-04","current":-3.218041,"twenty":-3.213082,"median":-2.414574,"eighty":-1.571411,"marketCap":34705930},{"date":"2025-04-11","current":-2.787743,"twenty":-3.202991,"median":-2.426108,"eighty":-1.57489,"marketCap":30065251},{"date":"2025-04-17","current":-2.879687,"twenty":-3.196825,"median":-2.432124,"eighty":-1.577667,"marketCap":31056849},{"date":"2025-04-25","current":-2.75832,"twenty":-3.194076,"median":-2.433596,"eighty":-1.58027,"marketCap":29747940},{"date":"2025-05-02","current":-2.721543,"twenty":-3.191201,"median":-2.435067,"eighty":-1.580778,"marketCap":29351300},{"date":"2025-05-09","current":-2.545304,"twenty":-3.184837,"median":-2.442315,"eighty":-1.584617,"marketCap":27450605},{"date":"2025-05-16","current":-2.640632,"twenty":-3.177217,"median":-2.449399,"eighty":-1.591135,"marketCap":28478694},{"date":"2025-05-23","current":-2.891668,"twenty":-3.175604,"median":-2.461477,"eighty":-1.59475,"marketCap":28161383},{"date":"2025-05-30","current":-2.848592,"twenty":-3.173691,"median":-2.467558,"eighty":-1.596495,"marketCap":27740172},{"date":"2025-06-06","current":-2.983655,"twenty":-3.171041,"median":-2.471533,"eighty":-1.597248,"marketCap":29055439},{"date":"2025-06-13","current":-3.090027,"twenty":-3.162815,"median":-2.474453,"eighty":-1.599877,"marketCap":30091311},{"date":"2025-06-20","current":-3.040954,"twenty":-3.151841,"median":-2.476911,"eighty":-1.604531,"marketCap":29613431},{"date":"2025-06-27","current":-3.04914,"twenty":-3.151841,"median":-2.483526,"eighty":-1.606931,"marketCap":29693144},{"date":"2025-07-03","current":-2.959671,"twenty":-3.147372,"median":-2.488018,"eighty":-1.607759,"marketCap":28821880},{"date":"2025-07-11","current":-3.163738,"twenty":-3.147372,"median":-2.492332,"eighty":-1.616416,"marketCap":30809128},{"date":"2025-07-18","current":-9.515772,"twenty":-3.16693,"median":-2.499125,"eighty":-1.619875,"marketCap":92666525},{"date":"2025-07-25","current":-7.776329,"twenty":-3.180002,"median":-2.517268,"eighty":-1.621437,"marketCap":75727483},{"date":"2025-08-01","current":-6.204692,"twenty":-3.200412,"median":-2.525634,"eighty":-1.622661,"marketCap":60422560},{"date":"2025-08-08","current":-5.181491,"twenty":-3.218054,"median":-2.534948,"eighty":-1.629275,"marketCap":50458417},{"date":"2025-08-15","current":-6.270177,"twenty":-3.250422,"median":-2.538446,"eighty":-1.632968,"marketCap":61060265},{"date":"2025-08-22","current":-5.997593,"twenty":-3.257382,"median":-2.543827,"eighty":-1.638429,"marketCap":67617758},{"date":"2025-08-29","current":-5.94544,"twenty":-3.263844,"median":-2.545304,"eighty":-1.640218,"marketCap":67029778},{"date":"2025-09-05","current":-5.516181,"twenty":-3.278064,"median":-2.551736,"eighty":-1.641884,"marketCap":62190246},{"date":"2025-09-12","current":-5.87724,"twenty":-3.289294,"median":-2.551736,"eighty":-1.647324,"marketCap":66260880},{"date":"2025-09-19","current":-6.158064,"twenty":-3.304249,"median":-2.556215,"eighty":-1.655567,"marketCap":69426929},{"date":"2025-09-26","current":-5.460016,"twenty":-3.321861,"median":-2.568606,"eighty":-1.659671,"marketCap":61557036},{"date":"2025-10-03","current":-6.202193,"twenty":-3.342434,"median":-2.573908,"eighty":-1.660375,"marketCap":69924451},{"date":"2025-10-10","current":-5.837122,"twenty":-3.378356,"median":-2.586724,"eighty":-1.661528,"marketCap":65808587},{"date":"2025-10-17","current":-5.792993,"twenty":-3.391631,"median":-2.588795,"eighty":-1.663151,"marketCap":65311065},{"date":"2025-10-24","current":-5.680663,"twenty":-3.410525,"median":-2.594566,"eighty":-1.663931,"marketCap":64044646},{"date":"2025-10-31","current":-5.556299,"twenty":-3.45894,"median":-2.600468,"eighty":-1.664376,"marketCap":62642538},{"date":"2025-11-07","current":-5.480075,"twenty":-3.514845,"median":-2.609453,"eighty":-1.664777,"marketCap":61783182},{"date":"2025-11-14","current":-5.303557,"twenty":-3.558021,"median":-2.613339,"eighty":-1.665437,"marketCap":59793094},{"date":"2025-11-21","current":-3.982874,"twenty":-3.61496,"median":-2.615129,"eighty":-1.665807,"marketCap":49209445},{"date":"2025-11-28","current":-3.993082,"twenty":-3.636245,"median":-2.617856,"eighty":-1.666732,"marketCap":49335569},{"date":"2025-12-05","current":-4.692156,"twenty":-3.694535,"median":-2.621305,"eighty":-1.66848,"marketCap":57972814},{"date":"2025-12-12","current":-4.768142,"twenty":-3.74198,"median":-2.636822,"eighty":-1.669233,"marketCap":58911645},{"date":"2025-12-19","current":-4.380612,"twenty":-3.798505,"median":-2.640435,"eighty":-1.671066,"marketCap":54123607},{"date":"2025-12-26","current":-4.521187,"twenty":-3.829663,"median":-2.641459,"eighty":-1.673333,"marketCap":55860444},{"date":"2026-01-02","current":-4.236238,"twenty":-3.919584,"median":-2.654432,"eighty":-1.673333,"marketCap":52339828},{"date":"2026-01-09","current":-4.711153,"twenty":-3.984396,"median":-2.658059,"eighty":-1.673333,"marketCap":58207522},{"date":"2026-01-16","current":-4.494592,"twenty":-3.997291,"median":-2.662761,"eighty":-1.67483,"marketCap":55531853},{"date":"2026-01-23","current":-4.695955,"twenty":-4.025289,"median":-2.66845,"eighty":-1.676882,"marketCap":58019755},{"date":"2026-01-30","current":-4.652263,"twenty":-4.091748,"median":-2.677362,"eighty":-1.684181,"marketCap":57479927},{"date":"2026-02-06","current":-4.186847,"twenty":-4.128815,"median":-2.678877,"eighty":-1.686479,"marketCap":51729588}],"updateTime":1770665321632},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INKT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608980350","title":"MiNK Therapeutics announces new invariant natural killer T cells data","url":"https://stock-news.laohu8.com/highlight/detail?id=2608980350","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608980350?lang=en_us&edition=fundamental","pubTime":"2026-02-04 18:25","pubTimestamp":1770200719,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics (INKT) announced that new translational data supporting the role of invariant natural killer T cells in idiopathic pulmonary fibr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-announces-new-invariant-natural-killer-t-cells-data-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-announces-new-invariant-natural-killer-t-cells-data-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INKT","BK4139"],"gpt_icon":0},{"id":"2608333891","title":"MiNK Therapeutics Unveils Data Supporting iNKT Cell Therapy for Advanced Idiopathic Pulmonary Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2608333891","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608333891?lang=en_us&edition=fundamental","pubTime":"2026-02-04 10:30","pubTimestamp":1770172214,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics Inc. has presented new translational data on its allo-iNKT cell therapy as a potential disease-modifying approach for idiopathic pulmonary fibrosis  at the Emerging Cell Therapies Meeting of the Keystone Symposia, held February 1-4, 2026, in Banff, Alberta, Canada. The data, presented by Dr. Terese Hammond, indicate a significant depletion of invariant natural killer T  cells in lung-associated lymph nodes from patients with advanced IPF. The company reported that these findings support the rationale for iNKT cell replenishment strategies as a potential method to restore immune balance and support tissue repair in fibrotic lung disease. The results were presented at the Keystone Symposia on February 3, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL8086sw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210150020.SGD","LU0314104364.USD","BK4585","IE00B3QW5Z07.USD","BK4588","IE00BGHQF748.EUR","INKT","LU2095319765.USD","IE00BKPKM429.USD","NDAQ","SG9999014013.SGD","IE00B64PRP62.GBP","BK4139","SG9999014039.USD","SG9999014005.SGD","LU2210149790.SGD","SG9999014021.USD"],"gpt_icon":0},{"id":"2602515391","title":"MiNK, University of Wisconsin-Madison announce Phase 1 agenT-797 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2602515391","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602515391?lang=en_us&edition=fundamental","pubTime":"2026-01-09 01:10","pubTimestamp":1767892224,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics (INKT) announced the upcoming initiation of a Phase 1, investigator-sponsored clinical trial evaluating its lead therapy, agenT-7...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mink-university-of-wisconsin-madison-announce-phase-1-agent-797-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mink-university-of-wisconsin-madison-announce-phase-1-agent-797-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INKT","BK4139"],"gpt_icon":0},{"id":"2602039945","title":"MiNK Therapeutics Wins Grants to Advance Phase 1 Trial of Allo-iNKT Cell Therapy for GvHD Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2602039945","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602039945?lang=en_us&edition=fundamental","pubTime":"2026-01-09 01:00","pubTimestamp":1767891615,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics Inc. has announced the initiation of a Phase 1 clinical trial of its lead therapy, agenT-797, for the prevention of graft-versus-host disease  in patients undergoing allogeneic hematopoietic stem cell transplantation. The trial is supported by two complementary public-private funding awards: an NIH STTR grant from the National Institute of Allergy and Infectious Diseases  and the Mary Gooze Clinical Trial and Translation Award to the University of Wisconsin-Madison. Both MiNK Therapeutics and the University of Wisconsin-Madison are beneficiaries of these grants, enabling the advancement of preclinical and clinical studies of allo-iNKT cell therapy in transplantation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mink","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL6t0MLp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4585","LU2210149790.SGD","INKT","SG9999014021.USD","SG9999014039.USD","IE00BKPKM429.USD","LU2210150020.SGD","BK4112","IE00BGHQF748.EUR","BK4588","NDAQ","SG9999014005.SGD","IE00B64PRP62.GBP","LU2095319765.USD","BK4139","LU0314104364.USD","SG9999014013.SGD"],"gpt_icon":0},{"id":"2602994323","title":"Mink Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-Inkt Cell Therapy (Agent-797) to Evaluate Prevention of Graft-Versus-Host Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2602994323","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602994323?lang=en_us&edition=fundamental","pubTime":"2026-01-09 01:00","pubTimestamp":1767891600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA53FS1T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INKT","BK4139"],"gpt_icon":0},{"id":"2600609875","title":"MiNK Therapeutics Director Robert Kadlec Resigns for U.S. Government Role","url":"https://stock-news.laohu8.com/highlight/detail?id=2600609875","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600609875?lang=en_us&edition=fundamental","pubTime":"2026-01-03 05:06","pubTimestamp":1767387962,"startTime":"0","endTime":"0","summary":"Robert Kadlec, MD, has resigned from the Board of Directors of MiNK Therapeutics, Inc., effective December 29, 2025. His departure follows his acceptance of a senior public service role within the United States government.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mink Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 02, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260102:nNDL7ZQP5x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INKT"],"gpt_icon":0},{"id":"2585156148","title":"MiNK Therapeutics Reports MiNK-215 Shows Strong Anti-Tumor Activity in Resistant Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2585156148","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585156148?lang=en_us&edition=fundamental","pubTime":"2025-11-21 00:42","pubTimestamp":1763656967,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics Inc. has announced new preclinical research results for its novel therapy, MiNK-215, which targets solid tumors resistant to current immunotherapies. The findings, now published in Cancer Immunology Research, show that MiNK-215-an IL-15-enhanced, FAP-targeting CAR-iNKT cell therapy-can effectively dismantle tumor-protective fibroblast barriers, remodel the tumor microenvironment, and activate multiple immune pathways. In models of lung and microsatellite stable  colorectal cancer, MiNK-215 promoted immune cell infiltration, activated dendritic cells, re-polarized macrophages, and enabled robust anti-tumor activity. As an off-the-shelf, allogeneic therapy, MiNK-215 offers a scalable treatment option for patients with solid tumors that have not responded to conventional immune-based therapies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL2JCzVp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00B3QW5Z07.USD","LU2095319765.USD","BK4588","INKT","IE00B64PRP62.GBP","LU2210150020.SGD","LU2210149790.SGD","IE00BGHQF748.EUR","NDAQ","BK4139","IE00BKPKM429.USD","BK4585","BK4112"],"gpt_icon":0},{"id":"2583833956","title":"MiNK Therapeutics: Advancing Clinical Trials and Strategic Partnerships to Address GvHD and Pulmonary Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2583833956","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583833956?lang=en_us&edition=fundamental","pubTime":"2025-11-15 00:55","pubTimestamp":1763139339,"startTime":"0","endTime":"0","summary":"In a report released today, Emily Bodnar from H.C. Wainwright maintained a Buy rating on MiNK Therapeutics, with a price target of $35.00. Emily Bo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/mink-therapeutics-advancing-clinical-trials-and-strategic-partnerships-to-address-gvhd-and-pulmonary-diseases-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/mink-therapeutics-advancing-clinical-trials-and-strategic-partnerships-to-address-gvhd-and-pulmonary-diseases-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","INKT"],"gpt_icon":0},{"id":"2583948509","title":"MiNK Therapeutics Q3 EPS $(0.65) Misses $(0.61) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583948509","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583948509?lang=en_us&edition=fundamental","pubTime":"2025-11-14 21:23","pubTimestamp":1763126597,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics (NASDAQ:INKT) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.61) by 5.69 percent. This is a 41.3 percent decrease over losses of $(0.46) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48862390/mink-therapeutics-q3-eps-0-65-misses-0-61-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT"],"gpt_icon":0},{"id":"2583459505","title":"MiNK Therapeutics reports Q3 EPS (65c) vs (46c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2583459505","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583459505?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:35","pubTimestamp":1763123756,"startTime":"0","endTime":"0","summary":"“This trial reflects the broader momentum of our iNKT platform as we expand into diseases marked by profound immune dysregulation,” said Dr. Terese...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-reports-q3-eps-65c-vs-46c-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-reports-q3-eps-65c-vs-46c-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INKT"],"gpt_icon":0},{"id":"2583686505","title":"Mink Therapeutics Q3 EPS USD -0.65","url":"https://stock-news.laohu8.com/highlight/detail?id=2583686505","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583686505?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:32","pubTimestamp":1763123532,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nPLX398BF9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INKT","BK4139"],"gpt_icon":0},{"id":"2583505685","title":"Mink Therapeutics Inc: Cash Runway Extended Through 2026, Enabling Multiple Inflection Points","url":"https://stock-news.laohu8.com/highlight/detail?id=2583505685","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583505685?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:30","pubTimestamp":1763123400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nTUA6TXZWL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INKT"],"gpt_icon":0},{"id":"2583505535","title":"Mink Therapeutics Reports Q3 2025 Results and Accelerates Inkt Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation","url":"https://stock-news.laohu8.com/highlight/detail?id=2583505535","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583505535?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:30","pubTimestamp":1763123400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nTUA6TXZWL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INKT"],"gpt_icon":0},{"id":"2583505358","title":"Press Release: MiNK Therapeutics Reports Q3 2025 Results and Accelerates iNKT Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation","url":"https://stock-news.laohu8.com/highlight/detail?id=2583505358","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583505358?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:30","pubTimestamp":1763123400,"startTime":"0","endTime":"0","summary":"-- New clinical data show durable remissions and long-tail survivors. -- GVHD trial launching through non-dilutive funding from NIH- and. -- Launching Phase 2+ trial in severe pulmonary disease in US population. -- Added national leaders in pulmonary medicine, trauma, and biodefense join. -- Cash runway extended through 2026, enabling multiple inflection points. -- Durable clinical responses in refractory solid tumors with agenT-797At. SITC 2025, MiNK reported updated clinical data showing sustained tumor. regression and immune reprogramming with its lead asset agenT-797 across. than two years and survival exceeding two and three years in late stage,Center--Madison, MiNK initiated a preclinical and Phase 1 study of. Jenny Gumperz, is supported by the Mary Gooze Clinical Trial and. \"This trial reflects the broader momentum of our iNKT platform as we expand into diseases marked by profound immune dysregulation,\" said Dr. Terese Hammond, Head of Inflammatory and Pulmonary","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT","BK4139"],"gpt_icon":0},{"id":"2581383400","title":"BRIEF-Mink Therapeutics Inc - Files For Mixed Shelf Offering Up To $150 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581383400","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581383400?lang=en_us&edition=fundamental","pubTime":"2025-11-08 06:11","pubTimestamp":1762553487,"startTime":"0","endTime":"0","summary":"BRIEF-Mink Therapeutics Inc - Files For Mixed Shelf Offering Up To $150 Million - SEC FilingMink Therapeutics Inc INKT.O:MINK THERAPEUTICS INC - FILES FOR MIXED SHELF OFFERING UP TO $150 MILLION - SEC FILINGSource text: [ID:n0001193125-25-272532]Further company coverage: INKT.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nFWN3WJ12L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INKT"],"gpt_icon":0},{"id":"2581783263","title":"MiNK Therapeutics files $150M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2581783263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581783263?lang=en_us&edition=fundamental","pubTime":"2025-11-08 06:00","pubTimestamp":1762552818,"startTime":"0","endTime":"0","summary":"16:58 EST MiNK Therapeutics (INKT) files $150M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-files-150m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-files-150m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","INKT"],"gpt_icon":0},{"id":"2581883890","title":"Promising Phase 1 Results for MiNK Therapeutics’ agenT-797 Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2581883890","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581883890?lang=en_us&edition=fundamental","pubTime":"2025-11-08 01:35","pubTimestamp":1762536937,"startTime":"0","endTime":"0","summary":"Analyst Emily Bodnar of H.C. Wainwright maintained a Buy rating on MiNK Therapeutics, retaining the price target of $35.00. Emily Bodnar’s rating i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-phase-1-results-for-mink-therapeutics-agent-797-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-phase-1-results-for-mink-therapeutics-agent-797-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INKT"],"gpt_icon":0},{"id":"2581882715","title":"BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton Interactive","url":"https://stock-news.laohu8.com/highlight/detail?id=2581882715","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581882715?lang=en_us&edition=fundamental","pubTime":"2025-11-08 00:01","pubTimestamp":1762531314,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton InteractiveEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nL6N3WJ0UZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DKNG","AFRM","PTON","VOYG","MCHP","WEN","SOLV","GIFI","CDE","NTLA","OLED","AKAM","RYTM","TTD","XYZ","GMED","FLGT","MNST","TSYW.SI","ANIP","GRND","IE00B19Z9Z06.USD","LDOS","TASK","HAE","CE","RRR","KKR","FLR","FROG","ABNB","HL","INKT","NEM","OGN","CEG","AIRS","CMI","TXG","INOD","CNH","BK4187"],"gpt_icon":1},{"id":"2581288952","title":"BUZZ-MiNK Therapeutics rises after data shows long-lasting remissions in tough cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2581288952","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581288952?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:24","pubTimestamp":1762525443,"startTime":"0","endTime":"0","summary":"BUZZ-MiNK Therapeutics rises after data shows long-lasting remissions in tough cancers** Shares of drug developer MiNK Therapeutics INKT.O rise 2% to $13.93 premarket ** Co says its experimental cell therapy, agenT-797, shows lasting benefits for patients with advanced cancers who had stopped responding to other treatments** INKT says patients who received agenT-797, either alone or with an existing immunotherapy drug, lived for a median of about 23 months** Some patients with tough-to-treat cancers, including testicular, thymoma, and gastric cancers, saw their disease controlled for more than two years - co** Doctors say that one patient with metastatic testicular cancer experienced a complete remission lasting over two years after receiving the combination therapy - INKT** Other patients with different cancers also saw their tumors shrink or stop growing for extended periods, co says** Up to last close, stock up 96% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nL4N3WJ19E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT","BK4139"],"gpt_icon":0},{"id":"2581898388","title":"MiNK Therapeutics reports updated clinical results on agenT-797","url":"https://stock-news.laohu8.com/highlight/detail?id=2581898388","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581898388?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:05","pubTimestamp":1762524354,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics (INKT) announced updated clinical results evaluating agenT-797, alone and in combination with anti-PD-1 therapy, in patients with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-reports-updated-clinical-results-on-agent-797-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-reports-updated-clinical-results-on-agent-797-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INKT","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}]}}